Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
DICP : the Annals of Pharmacotherapy
|
September 1, 1989
Do all histamine2-antagonists cause a warfarin drug interaction?
E K Hussey, G E Dukes
Pharmacotherapy
|
January 1, 1991
Albuterol extended-release products: a comparison of steady-state pharmacokinetics
E K Hussey, K H Donn, J R Powell
Journal of Clinical Pharmacology
|
March 10, 2000
A population pharmacokinetic analysis of zanamivir in subjects with experimental and naturally occurring influenza: effects of formulation and route of administration
A W Peng, E K Hussey, K H Moore
European Journal of Clinical Pharmacology
|
January 1, 1995
Single dose pharmacokinetics of sumatriptan in healthy volunteers
L F Lacey, E K Hussey, P A Fowler
Antiviral Therapy
|
May 7, 2003
Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection
D P Calfee, A W Peng, E K Hussey, et al.
The Journal of Infectious Diseases
|
December 12, 1997
Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza
J B Walker, E K Hussey, J J Treanor, et al.
Cephalalgia : an International Journal of Headache
|
June 1, 1997
Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses
K H Moore, E K Hussey, S Shaw, et al.
Journal of Clinical Pharmacology
|
June 1, 1991
Albuterol extended-release products: effect of food on the pharmacokinetics of single oral doses of Volmax and Proventil Repetabs in healthy male volunteers
E K Hussey, K H Donn, J R Powell, et al.
Journal of Clinical Pharmacology
|
December 1, 1995
Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine
G J Yuen, D M Morris, P K Mydlow, et al.
JAMA
|
January 24, 1996
Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza
F G Hayden, J J Treanor, R F Betts, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
DICP : the Annals of Pharmacotherapy
|
September 1, 1989
Do all histamine2-antagonists cause a warfarin drug interaction?
E K Hussey, G E Dukes
Pharmacotherapy
|
January 1, 1991
Albuterol extended-release products: a comparison of steady-state pharmacokinetics
E K Hussey, K H Donn, J R Powell
Journal of Clinical Pharmacology
|
March 10, 2000
A population pharmacokinetic analysis of zanamivir in subjects with experimental and naturally occurring influenza: effects of formulation and route of administration
A W Peng, E K Hussey, K H Moore
European Journal of Clinical Pharmacology
|
January 1, 1995
Single dose pharmacokinetics of sumatriptan in healthy volunteers
L F Lacey, E K Hussey, P A Fowler
Antiviral Therapy
|
May 7, 2003
Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection
D P Calfee, A W Peng, E K Hussey, et al.
The Journal of Infectious Diseases
|
December 12, 1997
Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza
J B Walker, E K Hussey, J J Treanor, et al.
Cephalalgia : an International Journal of Headache
|
June 1, 1997
Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses
K H Moore, E K Hussey, S Shaw, et al.
Journal of Clinical Pharmacology
|
June 1, 1991
Albuterol extended-release products: effect of food on the pharmacokinetics of single oral doses of Volmax and Proventil Repetabs in healthy male volunteers
E K Hussey, K H Donn, J R Powell, et al.
Journal of Clinical Pharmacology
|
December 1, 1995
Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine
G J Yuen, D M Morris, P K Mydlow, et al.
JAMA
|
January 24, 1996
Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza
F G Hayden, J J Treanor, R F Betts, et al.
Page
of 3